Dr. Giddings is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
UH Rainbow Babies and Children's Hospital
11100 Euclid Ave Department of Pediatrics-Pulmonary
Cleveland, OH 44106Phone+1 216-844-7700Fax+1 216-844-5916
Education & Training
University of North Carolina HospitalsFellowship, Pulmonary Disease and Critical Care Medicine, 2012 - 2015
Vanderbilt University Medical CenterResidency, Internal Medicine/Pediatrics, 2008 - 2012
Saint Louis University School of MedicineClass of 2008
Certifications & Licensure
OH State Medical License 2018 - 2025
NC State Medical License 2012 - 2019
TN State Medical License 2010 - 2014- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
- American Board of Pediatrics Pediatric Pulmonology
Clinical Trials
- S-Nitrosylation Therapy of COVID-19 Start of enrollment: 2021 Aug 05
Publications & Presentations
PubMed
- 2 citationsAntigen stasis and airway nitrosative stress in human primary ciliary dyskinesia.Benjamin Gaston, Laura A Smith, Michael D Davis, Jessica Saunders, Ivana Daniels
American Journal of Physiology. Lung Cellular and Molecular Physiology. 2024-04-01 - 3 citationsAirway Thiol-NO Adducts as Determinants of Exhaled NO.Megan Pophal, Zachary W. Grimmett, Clara Chu, Seunghee Margevicius, Thomas Raffay
Antioxidants. 2021-09-26 - 4 citationsA Treatment to Eliminate SARS-CoV-2 Replication in Human Airway Epithelial Cells Is Safe for Inhalation as an Aerosol in Healthy Human SubjectsMichael D Davis, Tatiana M. Clemente, Olivia K Giddings, Kristie R. Ross, Rebekah S Cunningham
Respiratory Care. 2021-01-01
Press Mentions
Athersys Announces Commencement of Patient Enrollment in the MACOVIA Study, a Pivotal Phase 2/3 Trial Evaluating MultiStem® Cell Therapy for COVID-19 Induced ARDSMay 5th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
